3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
4
Colorectal Neoplasms
3
Lymphoma
2
Colonic Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Medical Oncology
1
Malnutrition
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Glioma
1
Glioblastoma
1
Fasting
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Cancer Prevention
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
pembrolizumab
137
Cisplatin
75
Cetuximab
51
Carboplatin
49
Paclitaxel
39
Nivolumab
38
Radiotherapy
37
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Specimen Handling
20
Fluorouracil
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
atezolizumab
10
Surgical Procedures, Operative
10
Drug Therapy
10
Biopsy
9
durvalumab
8
Radiosurgery
8
130-nm albumin-bound paclitaxel
8
tislelizumab
7
Standard of Care
7
Chemoradiotherapy
7
Albumin-Bound Paclitaxel
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Diet
×
1 year
×
Clear all
No trials found.